EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Insights in Molecular Therapies for Hepatocellular Carcinoma

Philipp Heumann, Andreas Albert, Karsten Gülow, Deniz Tümen, Martina Müller, Arne Kandulski iD

Cancers · 10.05.2024 · 16 (10) · 1831

DOI: 10.3390/cancers16101831 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 10.05.2024. Verfasst von Philipp Heumann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 363 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We conducted a comprehensive review of the current literature of published data and clinical trials (MEDLINE), as well as published congress contributions and active recruiting clinical trials on targeted therapies in hepatocellular carcinoma. Combinations of different agents and medical therapy along with radiological interventions were analyzed for the setting of advanced HCC. Those settings were also analyzed in combination with adjuvant situations after resection or radiological treatments. We summarized the current knowledge for each therapeutic setting and combination that currently is or has been under clinical evaluation. We further discuss the results in the background of current treatment guidelines. In addition, we review the pathophysiological mechanisms and pathways for each of these investigated targets and drugs to further elucidate the molecular background and underlying mechanisms of action. Established and recommended targeted treatment options that already exist for patients are considered for systemic treatment: atezolizumab/bevacizumab, durvalumab/tremelimumab, sorafenib, lenvatinib, cabozantinib, regorafenib, and ramucirumab. Combination treatment for systemic treatment and local ablative treatment or transarterial chemoembolization and adjuvant and neoadjuvant treatment strategies are under clinical investigation.

Schlagwörter

Stichwörter der Autor:innen

hepatocellular carcinomamolecular directed therapytargeted therapy

Autor:innen und Institutionen

  • Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053 Regensburg, Germany.

ORCID-Profile: Arne Kandulski

Zitieren

APA

Heumann, P., Albert, A., Gülow, K., Tümen, D., Müller, M., & Kandulski, A. (2024). Insights in Molecular Therapies for Hepatocellular Carcinoma. Cancers, 16(10), 1831. https://doi.org/10.3390/cancers16101831

Vancouver

Heumann P, Albert A, Gülow K, Tümen D, Müller M, Kandulski A. Insights in Molecular Therapies for Hepatocellular Carcinoma. Cancers. 2024;16(10):1831. doi:10.3390/cancers16101831

BibTeX
@article{Heumann2024,
  author = {Heumann, Philipp and Albert, Andreas and Gülow, Karsten and Tümen, Deniz and Müller, Martina and Kandulski, Arne},
  title = {Insights in Molecular Therapies for Hepatocellular Carcinoma},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {10},
  pages = {1831},
  doi = {10.3390/cancers16101831}
}
Kostenlos starten →